Health eHeart BioBank
试验速览
- 阶段
- 不适用
- 状态
- Enrolling By Invitation
- 入组人数
- 500,000
- 试验地点
- 1
- 主要终点
- Establish and Maintain a Centralized Biorepository
研究概览
简要总结
The purpose of the Health eHeart BioBank is to collect and store specimen (e.g. blood, DNA, tissue) for future studies at the University of California, San Francisco (UCSF) that will help determine changes and identify molecular and genetic markers in the human body that might help increase our knowledge of heart disease and guide development of new diagnostic tools and treatments that may help rapidly detect heart disease and prevent and/or treat heart disease.
研究设计
- 研究类型
- Observational
- 观察模型
- Cohort
- 时间视角
- Cross Sectional
入排标准
- 年龄范围
- 18 Years 至 —（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 是
入选标准
- •Age ≥ 18 years or older.
- •And at least one of the following:
- •Established patient seen at UCSF and/or is a current participant in a clinical study that utilizes the HeH BioBank for biospecimen collection.
- •Family member of a patient with cardiovascular disease.
- •Patient with no cardiovascular disease.
排除标准
- •Unwilling to consent to biospecimen collection through the HeH BioBank.
研究组 & 干预措施
Participants with a History of Cardiovascular Disease
干预措施: Blood Draw (Procedure)
Participants with a History of Cardiovascular Disease
干预措施: Tissue Collection (Procedure)
Participants with a History of Cardiovascular Disease
干预措施: DNA Collection (Procedure)
Participants with a History of Cardiovascular Disease
干预措施: Medical Chart Review (Other)
Participants with a Family History of Cardiovascular Disease
干预措施: Blood Draw (Procedure)
Participants with a Family History of Cardiovascular Disease
干预措施: Tissue Collection (Procedure)
Participants with a Family History of Cardiovascular Disease
干预措施: DNA Collection (Procedure)
Participants with a Family History of Cardiovascular Disease
干预措施: Medical Chart Review (Other)
Healthy Controls
干预措施: Blood Draw (Procedure)
Healthy Controls
干预措施: Tissue Collection (Procedure)
Healthy Controls
干预措施: DNA Collection (Procedure)
Healthy Controls
干预措施: Medical Chart Review (Other)
结局指标
主要结局
Establish and Maintain a Centralized Biorepository
时间窗: Up to 10 years
Establish and maintain a centralized biorepository to collect and store a variety of biospecimen samples and clinical data. This would allow for the samples and clinical data to be used to test hypotheses regarding the molecular and genetic basis of diagnosis and treatment of cardiovascular diseases.
次要结局
未报告次要终点